118 related articles for article (PubMed ID: 3414142)
1. [Treatment of plasmacytoma with hyperviscosity syndrome].
Bosselmann HP; Gaede B; Franke A; Lachhein L
Z Gesamte Inn Med; 1988 May; 43(10):271-3. PubMed ID: 3414142
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic plasmapheresis in the treatment of plasmacytoma].
Quietzsch D; Kaltofen G; Eichhorn K
Z Gesamte Inn Med; 1981 Apr; 36(8):308-10. PubMed ID: 7281836
[TBL] [Abstract][Full Text] [Related]
3. [The effect of different programs of cytostatic therapy on the blood coagulation and rheological properties in multiple myeloma patients].
Katsadze IuL; Bessmel'tsev SS; Abdulkadyrov KM
Ter Arkh; 1991; 63(7):61-4. PubMed ID: 1788812
[TBL] [Abstract][Full Text] [Related]
4. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenström's type.
Höffkes HG; Heemann UW; Teschendorf C; Uppenkamp M; Philipp T
Clin Nephrol; 1995 May; 43(5):335-8. PubMed ID: 7634550
[TBL] [Abstract][Full Text] [Related]
5. [Polychemotherapy versus melphalan-prednisone in multiple myeloma].
Leoni P; Salvi A; Brianzoni MF; Centurioni R; Montillo M; Olivieri A
G Clin Med; 1986 Dec; 67(5-6):291-6. PubMed ID: 3609590
[No Abstract] [Full Text] [Related]
6. [Immunological and rheological disorders in multiple myeloma patients].
Abdulkadyrov KM; Bessmel'tsev SS; Liubimova NIu
Ter Arkh; 1991; 63(7):122-6. PubMed ID: 1788790
[TBL] [Abstract][Full Text] [Related]
7. Plasma cell problems: Case 2. Extramedullary cardiac plasmacytoma presenting with cardiac tamponade.
Chim CS; Loong F; Ma ES; Cheung W; Chan RH; Ooi GC
J Clin Oncol; 2005 May; 23(13):3140-3. PubMed ID: 15860874
[No Abstract] [Full Text] [Related]
8. [Acute renal failure in IgM plasmocytoma with hyperviscosity syndrome].
Nitschke M; Fink K; Pawlow-Handt S; Leeker A; Rob PM; Steinhoff J
Dtsch Med Wochenschr; 1997 Oct; 122(40):1213-6. PubMed ID: 9378045
[TBL] [Abstract][Full Text] [Related]
9. Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia.
Vela-Ojeda J; García-Ruiz Esparza MA; Rosas-Cabral A; Padilla-González Y; García-Chávez J; Tripp-Villanueva F; Sánchez-Cortés E; Ayala-Sánchez M; García-León LD; Montiel-Cervantes L; Rubio-Borja ME
Ann Hematol; 2002 Jul; 81(7):362-7. PubMed ID: 12185504
[TBL] [Abstract][Full Text] [Related]
10. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.
Oken MM; Harrington DP; Abramson N; Kyle RA; Knospe W; Glick JH
Cancer; 1997 Apr; 79(8):1561-7. PubMed ID: 9118039
[TBL] [Abstract][Full Text] [Related]
11. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR
Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252
[TBL] [Abstract][Full Text] [Related]
12. Improved outcome in solitary bone plasmacytomata with combined therapy.
Avilés A; Huerta-Guzmán J; Delgado S; Fernández A; Díaz-Maqueo JC
Hematol Oncol; 1996 Sep; 14(3):111-7. PubMed ID: 9119355
[TBL] [Abstract][Full Text] [Related]
13. [Results of polychemotherapy (a VMCP/VCAP program) in multiple myeloma].
Wutke K; Anger G
Z Gesamte Inn Med; 1983 Dec; 38(23):630-3. PubMed ID: 6689459
[TBL] [Abstract][Full Text] [Related]
14. [Interferon in the treatment of multiple myeloma].
Kuzmits R; Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Flener R; Scheithauer W
Acta Med Austriaca; 1985; 12(5):135-8. PubMed ID: 3914174
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy of breast cancer.
Cooper RG
Mt Sinai J Med; 1985 Jun; 52(6):443-6. PubMed ID: 3875023
[No Abstract] [Full Text] [Related]
16. The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486.
Oken MM; Leong T; Lenhard RE; Greipp PR; Kay NE; Van Ness B; Keimowitz RM; Kyle RA
Cancer; 1999 Sep; 86(6):957-68. PubMed ID: 10491521
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of multiple myeloma in stages II and III with melphalan, prednisone, cyclophosphamide, vincristine and BCNU (M-2 protocol)].
Montalbán C; Sevilla F; Zapatero A; Blanco L; Sabán J; Serrano M; Serrano Ríos M
Rev Clin Esp; 1985 May; 176(8):392-5. PubMed ID: 3839590
[No Abstract] [Full Text] [Related]
18. [Recent therapy for refractory myeloma].
Togawa A
Rinsho Ketsueki; 1993 Apr; 34(4):450-4. PubMed ID: 8510332
[TBL] [Abstract][Full Text] [Related]
19. Complete remission in plasma cell leukaemia.
Krsnik I; Peñalver MA; Del Potro E; Diaz-Mediavilla J
Br J Haematol; 1987 May; 66(1):145. PubMed ID: 3593651
[No Abstract] [Full Text] [Related]
20. Exceptionally long disease-free period in a case of Sézary syndrome after combined treatment with leukapheresis and chemotherapy.
Di Guglielmo R; Miliani A; Avanzi G; Cozzolino F; Duminuco M; Vannucci R; Occhini U
Haematologica; 1987; 72(6):541-3. PubMed ID: 3126113
[No Abstract] [Full Text] [Related]
[Next] [New Search]
